NCT05468827Completed
ICG Fluorescence Guided Lymph Node Mapping for Determination of Bowel Resection Margins in Colon Cancer
Source: ClinicalTrials.gov · Last updated 26 Jun 2025
Brief summary (registry, in English)
The study is aimed at investigating feasibility of defining colon resection margins for colon cancer with ICG by comparing lymphatic distribution of subserosally injected dye with actual spread of lymphatic metastases reported by pathologists after specimen examination
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 108 (actual)
- First submitted
- 18 Jul 2022
- Start date
- 26 Jul 2022
- Primary completion date
- 27 Feb 2024
- Lead sponsor
- N.N. Petrov National Medical Research Center of Oncology
- Diseases
- Colorectal cancer
- NCT number
- NCT05468827
What you commit to
- Study type: Interventional
- Participants enrolled: 108
- From 26 Jul 2022 to the primary completion date, 27 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Medical or psychiatric reasons interfering with patient's decision to participate in the study.
- Medical conditions contraindicating surgical procedure.
- Acute bowel obstruction, bleeding or perforation.
- Kidney failure of any aetiology
- Hepatic failure of any aetiology
Lab values
- Hypersensitivity to indocyanine green, sodium iodide or iodine
Other
- Pregnancy or breastfeeding.
- Hyperthyroidism or autonomic thyroid adenomas
- Poorly tolerated indocyanine injection in the past.
Who the study is looking for
- Pathologically confirmed adenocarcinoma of colon (caecum, ascending colon, hepatic flexure, transverse colon, splenic flexure, descending colon, sigmoid)
- TNM T1-4a N0-2 M0-1
- Clinical indications to colonic resection
- ECOG - 0-2
- Signed informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| N.N. Petrov National Medical Research Center of Oncology Coordinator of this site? Confirm its status | Saint Petersburg | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.